Mitochondria-assisted cell suicide: A license to kill

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 6, 2003, Pages 559-567

  Regula, Kelly M ^a,b   Ens, Karen ^a,b   Kirshenbaum, Lorrie A ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Bcl 2; Mitochondria; Ventricular myocytes

Indexed keywords

CYTOCHROME C; DIAZOXIDE; NICORANDIL; PROTEIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL X; PROTEIN BID; PROTEIN BNIP3; PROTEIN MCL 1; PROTEIN NIX; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; B CELL LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE PERMEABILITY; CELL ULTRASTRUCTURE; CITRIC ACID CYCLE; CORONARY ARTERY BLOOD FLOW; GENE TRANSLOCATION; GENETIC REGULATION; HEART DEATH; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SRC HOMOLOGY DOMAIN; STRUCTURAL HOMOLOGY;

EID: 0037604666     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00118-4     Document Type: Review

References (90)

1. Wyllie A.H. Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer. 67:(2):1993;205-208.
2. Wyllie A.H. Apoptosis. Death gets a brake [news; comment]. Nature. 369:(6478):1994;272-273.
3. Arends M.J., Wyllie A.H. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 32:1991;223-254.
4. Wyllie A.H. The genetic regulation of apoptosis. Curr Opin Genet Dev. 5:(1):1995;97-104.
5. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metast Rev. 11:(2):1992;95-103.
6. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:(5203):1995;1456-1462.
7. Eastman A., Grant S., Lock R., Tritton T., Van Houten N., Yuan J. Cell death in cancer and development. AACR special conference in cancer research. Cancer Res. 54:(10):1994;2812-2818.
8. Martin S.J., Green D.R. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol. 18:(2):1995;137-153.
9. Tanaka M., Ito H., Adachi S., Akimoto H., Nishikawa T., Kasajima T., et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:(3):1994;426-433.
10. Moissac D., Gurevich R.M., Zheng H., Singal P.K., Kirshenbaum L.A. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol. 32:(1):2000;53-63.
11. Webster K.A., Discher D.J., Kaiser S., Hernandez O., Sato B. Bishopric NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest. 104:(3):1999;239-252.
12. Gottlieb R.A., Gruol D.L., Zhu J.Y., Engler R.L. Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 97:(10):1996;2391-2398.
13. Kajstura J., Cheng W., Reiss K., Clark W.A.R. Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:(1):1996;86-107.
14. Narula J., Haider N., Virmani R., DiSalvo T.G., Kolodgie F.D., Hajjar R.J., et al. Apoptosis in myocytes in end-stage heart failure [see comments]. N Engl J M. 335:(16):1996;1182-1189.
15. Quaini F., Cigola E., Lagrasta C., Saccani G., Quaini E., Rossi C., et al. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res. 75:1994;1050-1063.
16. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:(11):1995;2703-2711.
17. James T.N. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 90:(1):1994;556-573.
18. Hengartner M.O., Horvitz H.R. Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev. 4:(4):1994;581-586.
19. Hengartner M.O., Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 76:(4):1994;665-676.
20. Lu Q.L., Hanby A.M., Nasser Hajibagheri M.A., Gschmeissner S.E., Lu P.J., Taylor Papadimitriou J., et al. Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci. 107:(Pt 2):1994;363-371.
21. Reed J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol. 7:(6):1995;541-546.
22. Korsmeyer S.J., Arnold A., Bakhshi A., Ravetch J.V., Siebenlist U., Hieter P.A., et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 71:(2):1983;301-313.
23. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA. 92:(17):1995;7834-7838.
24. Korsmeyer S.J. Programmed cell death: Bcl-2. Import Adv Oncol. 1993;19-28.
25. Hunter J.J., Bond B.L., Parslow T.G. Functional dissection of the human Bc12 protein: sequence requirements for inhibition of apoptosis. Mol Cell Biol. 16:(3):1996;877-883.
26. Hanada M., Aime Sempe C., Sato T., Reed J.C. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem. 270:(20):1995;11962-11969.
27. Yin X.M., Oltvai Z.N. Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [see comments]. Nature. 369:(6478):1994;321-323.
28. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:(6580):1996;335-341.
29. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:(2):1995;285-291.
30. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:(5381):1998;1309-1312.
31. Minn A.J., Velez P., Schendel S.L., Liang H., Muchmore S.W., Fesik S.W., et al. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 385:(6614):1997;353-357.
32. Kumar S. ICE-like proteases in apoptosis. Trend Biochem Sci. 20:(5):1995;198-202.
33. Thornberry N.A., Molineaux S.M. Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci. 4:(1):1995;3-12.
34. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., et al. Human ICE/CED-3 protease nomenclature [letter]. Cell. 87:(2):1996;171.
35. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem. 274:(32):1999;22532-22538.
36. Kuwana T., Smith J.J., Muzio M., Dixit V., Newmeyer D.D., Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem. 273:(26):1998;16589-16594.
37. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 144:(2):1999;281-292.
38. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:(5381):1998;1312-1316.
39. Korsmeyer S.J. Regulators of cell death. Trend Genet. 11:(3):1995;101-105.
40. Gulbins E., Dreschers S., Bock J. Role of mitochondria in apoptosis. Exp Physiol. 88:(Pt 1):2003;85-90.
41. Chandra D., Tang D.G. Mitochondrially-localized active caspase-9 and caspase-3 result mostly from translocation from the cytosol and partly from caspase-mediated activation in the organelle - lack of evidence for Apaf-1-mediated procaspase-9 activation in the mitochondria. J Biol Chem. 2003;. (in press).
42. Crompton M., Virji S., Doyle V., Johnson N., Ward J.M. The mitochondrial permeability transition pore. Biochem Soc Symp. 66:1999;167-179.
43. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:(5303):1997;1129-1132.
44. Martin A.G., Fearnhead H.O. Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J Biol Chem. 277:(52):2002;50834-50841.
45. Tikoo A., O'Reilly L., Day C.L., Verhagen A.M., Pakusch M., Vaux D.L. Tissue distribution of Diablo/Smac revealed by monoclonal antibodies. Cell Death Differ. 9:(7):2002;710-716.
46. Silke J., Hawkins C.J., Ekert P.G., Chew J., Day C.L., Pakusch M., et al. The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites. J Cell Biol. 157:(1):2002;115-124.
47. Holcik M., Korneluk R.G. XIAP, the guardian angel. Nat Rev Mol Cell Biol. 2:(7):2001;550-556.
48. Li W., Srinivasula S.M., Chai J., Li P., Wu J.W., Zhang Z., et al. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat Struct Biol. 9:(6):2002;436-441.
49. Cilenti L., Lee Y., Hess S., Srinivasula S., Park K.M., Junqueira D., et al. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. J Biol Chem. 278:(13):2003;11489-11494.
50. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Brenner C., Larochette N., et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp M. 189:(2):1999;381-394.
51. Costantini P., Bruey J.M., Castedo M., Metivier D., Loeffler M., Susin S.A., et al. Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ. 9:(1):2002;82-88.
52. Lorenzo H.K., Susin S.A., Penninger J., Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6:(6):1999;516-524.
53. Cande C., Cecconi F., Dessen P., Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci. 115:(Pt 24):2002;4727-4734.
54. 2+-induced mitochondrial permeability transition causes complete release of rat liver endonuclease G activity from its exclusive location within the mitochondrial intermembrane space. Identification of a novel endo-exonuclease activity residing within the mitochondrial matrix. Nucleic Acids Res. 31:(4):2003;1364-1373.
55. Gerschenson M., Houmiel K.L., Low R.L. Endonuclease G from mammalian nuclei is identical to the major endonuclease of mitochondria. Nucleic Acids Res. 23:(1):1995;88-97.
56. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA. 95:(25):1998;14681-14686.
57. Bernardi P., Colonna R., Costantini P., Eriksson O., Fontaine E., Ichas F., et al. The mitochondrial permeability transition. Biofactors. 8:(3-4):1998;273-281.
58. Martinou J.C., Green D.R. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol. 2:(1):2001;63-67.
59. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA. 95:(25):1998;14681-14686.
60. Antonsson B., Montessuit S., Lauper S., Eskes R., Martinou J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J. 345:(Pt 2):2000;271-278.
61. Goping I.S., Gross A., Lavoie J.N., Nguyen M., Jemmerson R., Roth K., et al. Regulated targeting of BAX to mitochondria. J Cell Biol. 143:(1):1998;207-215.
62. Eskes R., Desagher S., Antonsson B., Martinou J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol. 20:(3):2000;929-935.
63. Gross A., Jockel J., Wei M.C., Korsmeyer S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:(14):1998;3878-3885.
64. Shimizu S., Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc Natl Acad Sci USA. 97:(2):2000;577-582.
65. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC [see comments]. Nature. 399:(6735):1999;483-487.
66. Bradham C.A., Qian T., Streetz K., Trautwein C., Brenner D.A., Lemasters J.J. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol. 18:(11):1998;6353-6364.
67. Huang D.C., Strasser A. BH3-only proteins-essential initiators of apoptotic cell death. Cell. 103:(6):2000;839-842.
68. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:(4):1998;491-501.
69. Chen M., Won D.J., Krajewski S., Gottlieb R.A. Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem. 277:(32):2002;29181-29186.
70. Shimizu S., Konishi A., Kodama T., Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci USA. 97:(7):2000;3100-3105.
71. Zha H., Reed J.C. Heterodimerization-independent functions of cell death regulatory proteins bax and bcl-2 in yeast and mammalian cells [in process citation]. J Biol Chem. 272:(50):1997;31482-31488.
72. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:(5381):1998;1322-1326.
73. Singal P.K., Kirshenbaum L.A. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol. 6:(2):1990;47-49.
74. Hill M.F., Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol. 148:(1):1996;291-300.
75. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J M. 339:(13):1998;900-905.
76. von Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99:(22):1999;2934-2941.
77. Neuss M., Monticone R., Lundberg M.S., Chesley A.T., Fleck E., Crow M.T. The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem. 276:(36):2001;33915-33922.
78. Gustafsson A.B., Sayen M.R., Williams S.D., Crow M.T., Gottlieb R.A. TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective. Circulation. 106:(6):2002;735-739.
79. Akao M., Teshima Y., Marban E. Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes. J Am Coll Cardiol. 40:(4):2002;803-810.
80. Gurevich R.M., Regula K.M., Kirshenbaum L.A. Serpin protein CrmA suppresses hypoxia-mediated apoptosis of ventricular myocytes. Circulation. 103:(15):2001;1984-1991.
81. Bialik S., Cryns V.L., Drincic A., Miyata S., Wollowick A.L., Srinivasan A., et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res. 85:(5):1999;403-414.
82. Malhotra R., Brosius F.C. III. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem. 274:(18):1999;12567-12575.
83. Yasuda M., Theodorakis P., Subramanian T., Chinnadurai G. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem. 273:(20):1998;12415-12421.
84. Regula K.M., Ens K., Kirshenbaum L.A. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res. 91:(3):2002;226-231.
85. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3.
86. Vande V.C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol. 20:(15):2000;5454-5468.
87. Chen G., Ray R., Dubik D., Shi L., Cizeau J., Bleackley R.C., et al. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J Exp M. 186:(12):1997;1975-1983.
88. Chen G., Cizeau J., Vande V.C., Park J.H., Bozek G., Bolton J., et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem. 274:(1):1999;7-10.
89. Oral H., Dorn G.W., Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem. 272:(8):1997;4836-4842.
90. Guo K., Searfoss G., Krolikowski D., Pagnoni M., Franks C., Clark K., et al. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 8:(4):2001;367-376.